Home » Newsletters » BioWorld Science

BioWorld Science

June 9, 2010

View Archived Issues

Irinotecan/S-1 active in 5-FU-resistant bladder cancer cell lines

Fast-dissolving desmopressin is safe in adults with nocturia

Two placebo-controlled trials show safety of CX-157

New GABA(A) receptor modulators claimed by NeuroSearch

Merck & Co. discloses new FABP inhibitors

Merck & Co. describes new gamma-secretase modulators

Nycomed presents new PDE4B inhibitors

Arbaclofen placarbil improves sleep quality in PPI-responsive GERD

Antitumor agent MSC-1936369B shows safety in phase I trial

NTx described as biomarker for prediction of bone metastasis in lung cancer

Bortezomib linked to heart failure in patients with multiple myeloma

PTC receives award to develop anticancer drugs targeting BMI-1

Merck Serono resubmits cladribine tablets NDA for relapsing MS to FDA

Benlysta MAA submitted to EMA for SLE

Can-Fite opens new CF-101 IND with phase II/III trial protocol in psoriasis

VIVUS' avanafil improves ED in phase III trial in diabetic men

Auxilium reports 2-year recurrence data on Xiaflex

AVI BioPharma and DTRA enter into new contract for AVI-7100

Phico Therapeutics' PT1.2 safe and well tolerated in phase I trial

Zealand Pharma and sanofi-aventis extend lixisenatide licensing agreement

Telik reports phase II data on ezatiostat in MDS

Adeona advances enrollment in part 2 of CopperProof-2 trial in AD

Immunovaccine and Vaxil join to advance potential cancer vaccine

Cellceutix expedites studies of KM-391 and Kevetrin

Opal Therapeutics and MGH to jointly develop HIV vaccine

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...